Copyright Reports & Markets. All rights reserved.

Global Epigenetics Instrument Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Epigenetics Instrument Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Epigenetics Instrument Market Size Growth Rate by Product
      • 1.4.2 Next-generation Sequencers
      • 1.4.3 qPCR Instruments
      • 1.4.4 Mass Spectrometers
      • 1.4.5 Sonicators
      • 1.4.6 Other
    • 1.5 Market by End User
      • 1.5.1 Global Epigenetics Instrument Market Size Growth Rate by End User
      • 1.5.2 Oncology
      • 1.5.3 Metabolic Diseases
      • 1.5.4 Developmental Biology
      • 1.5.5 Immunology
      • 1.5.6 Cardiovascular Diseases
      • 1.5.7 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Epigenetics Instrument Market Size
      • 2.1.1 Global Epigenetics Instrument Revenue 2014-2025
      • 2.1.2 Global Epigenetics Instrument Sales 2014-2025
    • 2.2 Epigenetics Instrument Growth Rate by Regions
      • 2.2.1 Global Epigenetics Instrument Sales by Regions
      • 2.2.2 Global Epigenetics Instrument Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Epigenetics Instrument Sales by Manufacturers
      • 3.1.1 Epigenetics Instrument Sales by Manufacturers
      • 3.1.2 Epigenetics Instrument Sales Market Share by Manufacturers
      • 3.1.3 Global Epigenetics Instrument Market Concentration Ratio (CR5 and HHI)
    • 3.2 Epigenetics Instrument Revenue by Manufacturers
      • 3.2.1 Epigenetics Instrument Revenue by Manufacturers (2014-2019)
      • 3.2.2 Epigenetics Instrument Revenue Share by Manufacturers (2014-2019)
    • 3.3 Epigenetics Instrument Price by Manufacturers
    • 3.4 Epigenetics Instrument Manufacturing Base Distribution, Product Types
      • 3.4.1 Epigenetics Instrument Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Epigenetics Instrument Product Type
      • 3.4.3 Date of International Manufacturers Enter into Epigenetics Instrument Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Epigenetics Instrument Sales by Product
    • 4.2 Global Epigenetics Instrument Revenue by Product
    • 4.3 Epigenetics Instrument Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Epigenetics Instrument Breakdown Data by End User

    6 North America

    • 6.1 North America Epigenetics Instrument by Countries
      • 6.1.1 North America Epigenetics Instrument Sales by Countries
      • 6.1.2 North America Epigenetics Instrument Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Epigenetics Instrument by Product
    • 6.3 North America Epigenetics Instrument by End User

    7 Europe

    • 7.1 Europe Epigenetics Instrument by Countries
      • 7.1.1 Europe Epigenetics Instrument Sales by Countries
      • 7.1.2 Europe Epigenetics Instrument Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Epigenetics Instrument by Product
    • 7.3 Europe Epigenetics Instrument by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Epigenetics Instrument by Countries
      • 8.1.1 Asia Pacific Epigenetics Instrument Sales by Countries
      • 8.1.2 Asia Pacific Epigenetics Instrument Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Epigenetics Instrument by Product
    • 8.3 Asia Pacific Epigenetics Instrument by End User

    9 Central & South America

    • 9.1 Central & South America Epigenetics Instrument by Countries
      • 9.1.1 Central & South America Epigenetics Instrument Sales by Countries
      • 9.1.2 Central & South America Epigenetics Instrument Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Epigenetics Instrument by Product
    • 9.3 Central & South America Epigenetics Instrument by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Epigenetics Instrument by Countries
      • 10.1.1 Middle East and Africa Epigenetics Instrument Sales by Countries
      • 10.1.2 Middle East and Africa Epigenetics Instrument Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Epigenetics Instrument by Product
    • 10.3 Middle East and Africa Epigenetics Instrument by End User

    11 Company Profiles

    • 11.1 Illumina (US)
      • 11.1.1 Illumina (US) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Illumina (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Illumina (US) Epigenetics Instrument Products Offered
      • 11.1.5 Illumina (US) Recent Development
    • 11.2 Thermo Fisher (US)
      • 11.2.1 Thermo Fisher (US) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Thermo Fisher (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Thermo Fisher (US) Epigenetics Instrument Products Offered
      • 11.2.5 Thermo Fisher (US) Recent Development
    • 11.3 Diagenode (Belgium)
      • 11.3.1 Diagenode (Belgium) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Diagenode (Belgium) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Diagenode (Belgium) Epigenetics Instrument Products Offered
      • 11.3.5 Diagenode (Belgium) Recent Development
    • 11.4 QIAGEN (Netherlands)
      • 11.4.1 QIAGEN (Netherlands) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 QIAGEN (Netherlands) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 QIAGEN (Netherlands) Epigenetics Instrument Products Offered
      • 11.4.5 QIAGEN (Netherlands) Recent Development
    • 11.5 Merck Millipore (US)
      • 11.5.1 Merck Millipore (US) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Merck Millipore (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Merck Millipore (US) Epigenetics Instrument Products Offered
      • 11.5.5 Merck Millipore (US) Recent Development
    • 11.6 Abcam (UK)
      • 11.6.1 Abcam (UK) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Abcam (UK) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Abcam (UK) Epigenetics Instrument Products Offered
      • 11.6.5 Abcam (UK) Recent Development
    • 11.7 Active Motif (US)
      • 11.7.1 Active Motif (US) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Active Motif (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Active Motif (US) Epigenetics Instrument Products Offered
      • 11.7.5 Active Motif (US) Recent Development
    • 11.8 New England Biolabs (US)
      • 11.8.1 New England Biolabs (US) Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 New England Biolabs (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 New England Biolabs (US) Epigenetics Instrument Products Offered
      • 11.8.5 New England Biolabs (US) Recent Development
    • 11.9 Agilent (US)
      • 11.9.1 Agilent (US) Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Agilent (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Agilent (US) Epigenetics Instrument Products Offered
      • 11.9.5 Agilent (US) Recent Development
    • 11.10 Zymo Research (US)
      • 11.10.1 Zymo Research (US) Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Zymo Research (US) Epigenetics Instrument Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Zymo Research (US) Epigenetics Instrument Products Offered
      • 11.10.5 Zymo Research (US) Recent Development
    • 11.11 PerkinElmer (US)
    • 11.12 Bio-Rad (US)

    12 Future Forecast

    • 12.1 Epigenetics Instrument Market Forecast by Regions
      • 12.1.1 Global Epigenetics Instrument Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Epigenetics Instrument Revenue Forecast by Regions 2019-2025
    • 12.2 Epigenetics Instrument Market Forecast by Product
      • 12.2.1 Global Epigenetics Instrument Sales Forecast by Product 2019-2025
      • 12.2.2 Global Epigenetics Instrument Revenue Forecast by Product 2019-2025
    • 12.3 Epigenetics Instrument Market Forecast by End User
    • 12.4 North America Epigenetics Instrument Forecast
    • 12.5 Europe Epigenetics Instrument Forecast
    • 12.6 Asia Pacific Epigenetics Instrument Forecast
    • 12.7 Central & South America Epigenetics Instrument Forecast
    • 12.8 Middle East and Africa Epigenetics Instrument Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Epigenetics Instrument Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Epigenetics Instrument market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epigenetics Instrument market based on company, product type, end user and key regions.

      This report studies the global market size of Epigenetics Instrument in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epigenetics Instrument in these regions.
      This research report categorizes the global Epigenetics Instrument market by top players/brands, region, type and end user. This report also studies the global Epigenetics Instrument market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Illumina (US)
      Thermo Fisher (US)
      Diagenode (Belgium)
      QIAGEN (Netherlands)
      Merck Millipore (US)
      Abcam (UK)
      Active Motif (US)
      New England Biolabs (US)
      Agilent (US)
      Zymo Research (US)
      PerkinElmer (US)
      Bio-Rad (US)

      Market size by Product
      Next-generation Sequencers
      qPCR Instruments
      Mass Spectrometers
      Sonicators
      Other
      Market size by End User
      Oncology
      Metabolic Diseases
      Developmental Biology
      Immunology
      Cardiovascular Diseases
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Epigenetics Instrument market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Epigenetics Instrument market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Epigenetics Instrument companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Epigenetics Instrument submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Epigenetics Instrument are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epigenetics Instrument market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now